title: Bortezomib to treat the TEMPI syndrome.
authors.forename: Mary
authors.initials: M
authors.lastname: Kwok
authors.forename: Neha
authors.initials: N
authors.lastname: Korde
authors.forename: Ola
authors.initials: O
authors.lastname: Landgren
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D004921:Erythropoietin / Q000097:blood; D005260:Female; D006801:Humans; D008200:Lymphangiectasis; D008875:Middle Aged; D010265:Paraproteinemias / Q000188:drug therapy*; D011086:Polycythemia / Q000188:drug therapy*; D011719:Pyrazines / Q000627:therapeutic use*; D013577:Syndrome; D013684:Telangiectasis / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D004921:Erythropoietin; D000069286:Bortezomib